Semaglutide is a medication intended to stimulate GLP-1 receptors, which helps lower blood sugar levels in individuals with type 2 diabetes. It was approved by the FDA in 2017 as it also assists the body in increasing insulin levels and suppressing appetite. In 2021, it also received approval for treating obesity due to its effectiveness in promoting weight loss. Semaglutide has prove... https://longevityhealthplans.com/